u/draw_up_dizzy

Have you seen the special authorization criteria for your province?

glucagon agonism and energy expenditure is the mechanistic thread

Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.

ask what the beyond-use date is based on

glucagon agonism and energy expenditure is the mechanistic thread

Cosigning that protein gets harder precisely when appetite drops. That is the actual difficulty and it is logistical.

This. Intention-to-treat versus completer analysis routinely moves the headline by several points.

Argued for a week about a result and then read the limitations section, which conceded most of my opponent’s point.

plan the maintenance phase before you need it

potency testing on the finished preparation is the thing to ask for

monthly weigh-ins are enough at this stage

discontinuation rate is a result, not a footnote

Same. Monthly is plenty at this stage and daily weighing made me miserable for no information gain.

read the endpoint before you read the headline

vendor source pages link storefronts and the link is marked

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

Same. Very thin independent data on this one, which should make everybody here more tentative than they are.

Assumed the weight numbers were the point and was corrected. They are secondary to what this is being developed for.

evidence rules are strict here on purpose

Edited a wiki page for the first time and nothing bad happened, which is apparently the point.

Are you comparing against your own baseline or against a published average?

Yes.

Agreed — and same machine, same conditions, or the two scans are not comparable.

intention to treat versus completers changes the number substantially

Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the appli

Disagreeing with this line: that is an employer plan process and the provincial one differs.

Moved provinces and the coverage position changed completely. Same person, same history, different formulary.

Was this a denied authorization or a rejected claim?

Have you asked the pharmacist to check?

Did they name the facility?

the criteria change at plan renewal and nobody announces it

Agreed — write the application against the published criteria rather than around them.

Checked the sponsor disclosure because I assumed it would be vague. It was extremely specific and slightly boring.

Read the ranking formula out of scepticism and reproduced the ordering in a spreadsheet. It does what it says.

Have the lifts held, dropped, or moved around?

Yes. Approval and coverage are separate, and this board conflates them in about half its threads.

the shortage list is the whole legal hinge and people skip it

Agreed.

hub_ops is right about the programme names. They are different populations with different endpoints.

Spent an evening on the histology scoring system and understood the trial literature far better afterwards.

the archive-after-a-year policy is deliberate

Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.